Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. World most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations. CA Most cancers J Clin. 2021;71:209–49.
Ge N, Yan G, Solar H, Yang L, Kong L, Solar Y, Han Y, Zhao Q, Kang S, et al. Model updating of technique for drug discovery primarily based on efficient constituents of conventional Chinese language medicines. Acupunct Herb Med. 2023. https://doi.org/10.1097/hm9.0000000000000071.
Ashrafizadeh M, Zarrabi A, Bigham A, Taheriazam A, Saghari Y, Mirzaei S, Hashemi M, Hushmandi Okay, Karimi-Maleh H, et al. (Nano)platforms in breast most cancers remedy: drug/gene supply, superior nanocarriers and immunotherapy. Med Res Rev. 2023;43:2115–76.
Pedrazzoli S. Presently debated subjects on surgical remedy of pancreatic ductal adenocarcinoma: a story overview on surgical remedy of borderline resectable, domestically superior, and synchronous or metachronous oligometastatic tumor. J Clin Med. 2023;12:6461.
Gemenetzis G, Groot VP, Blair AB, Laheru DA, Zheng L, Narang AK, Fishman EK, Hruban RH, Yu J, et al. Survival in domestically superior pancreatic most cancers after neoadjuvant remedy and surgical resection. Ann Surg. 2019;270:340–7.
An L, Li M, Jia Q. Mechanisms of radiotherapy resistance and radiosensitization methods for esophageal squamous cell carcinoma. Mol Most cancers. 2023;22:140.
Smyth MJ, Ngiow SF, Ribas A, Teng MW. Mixture most cancers immunotherapies tailor-made to the tumour microenvironment. Nat Rev Clin Oncol. 2016;13:143–58.
Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184:5309–37.
Galon J, Bruni D. Approaches to deal with immune scorching, altered and chilly tumours with mixture immunotherapies. Nat Rev Drug Discov. 2019;18:197–218.
Chen Z, Chen L, Ma Y, Liu Y, Zhang Q, Qin H, Chen Y, Tian B, Dong J. Peptide-appended nanosonosensitizers focusing on tumor glycolysis for synergistic sonodynamic-immunometabolic remedy of spinal-metastasized tumors. Adv Mater. 2023;35: e2304246.
Shao Y, Su R, Wang Y, Yin S, Pu W, Koo S, Yu H. Drug co-administration within the tumor immune microenvironment of Hepatocellular carcinoma. Acupunct Herb Med. 2023;3:189–99.
Liu Y, Li M, Ding J, Chen X. Glycoengineering-assistant biomineralization for tumor blockade therap y. Chin Chem Lett. 2024. https://doi.org/10.1016/j.cclet.2024.110146:110146.
Chen B, Guo Okay, Zhao X, Liu Z, Xu C, Zhao N, Xu FJ. Tumor microenvironment-responsive supply nanosystems reverse immunosuppression for enhanced CO gasoline/immunotherapy. Exploration. 2023;3:20220140.
Gao D, Asghar S, Hu R, Chen S, Niu R, Liu J, Chen Z, Xiao Y. Latest advances in numerous nanosystems for nitric oxide supply in most cancers remedy. Acta Pharm Sin B. 2023;13:1498–521.
Zheng Y, Ji X, Ji Okay, Wang B. Hydrogen sulfide prodrugs—a overview. Acta Pharmaceutica Sinica B. 2015;5:367–77.
Oza PP, Kashfi Okay. The triple crown: NO, CO, and H(2)S in most cancers cell biology. Pharmacol Ther. 2023;249: 108502.
Zhou J, Cao C, Zhang X, Zhang X, Li J, Deng H, Wang S. Gasoline-assisted phototherapy for most cancers remedy. J Management Launch. 2023;360:564–77.
Ji P, Yang Okay, Xu Q, Qin G, Zhu Q, Qian Y, Yao W. Mechanisms and utility of gas-based anticancer therapies. Prescribed drugs. 2023;16:1394.
He P, Ren X, Zhang Y, Tang B, Xiao C. Latest advances in sulfur dioxide releasing nanoplatforms for most cancers remedy. Acta Biomater. 2024;174:91–103.
Xiao C, Solar Y, Fan J, Nguyen W, Chen S, Lengthy Y, Chen W, Zhu A, Liu B. Engineering cannabidiol synergistic carbon monoxide nanocomplexes to reinforce most cancers remedy through extreme autophagy. Acta Pharm Sin B. 2023;13:4591–606.
Wang Y, Yang T, He Q. Methods for engineering superior nanomedicines for gasoline remedy of most cancers. Natl Sci Rev. 2020;7:1485–512.
Zhao Z, Shan X, Zhang H, Shi X, Huang P, Solar J, He Z, Luo C, Zhang S. Nitric oxide-driven nanotherapeutics for most cancers remedy. J Management Launch. 2023;362:151–69.
Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, Xie J. Nitric oxide: physiological features, supply, and biomedical purposes. Adv Sci. 2023;10: e2303259.
Jin G, Gao Z, Liu Y, Zhao J, Ou H, Xu F, Ding D. Polymeric nitric oxide supply nanoplatforms for treating most cancers, cardiovascular illnesses, and an infection. Adv Healthc Mater. 2021;10: e2001550.
Li CY, Anuraga G, Chang CP, Weng TY, Hsu HP, Ta HDK, Su PF, Chiu PH, Yang SJ, et al. Repurposing nitric oxide donating medication in most cancers remedy by way of immune modulation. J Exp Clin Most cancers Res. 2023;42:22.
Shi M, Zhang J, Wang Y, Peng C, Hu H, Qiao M, Zhao X, Chen D. Tumor-specific nitric oxide generator to amplify peroxynitrite primarily based on extremely penetrable nanoparticles for metastasis inhibition and enhanced most cancers remedy. Biomaterials. 2022;283: 121448.
Kim T, Suh J, Kim J, Kim WJ. Lymph-directed self-immolative nitric oxide prodrug for inhibition of intractable metastatic most cancers. Adv Sci. 2022;9:2101935.
Li Y, Yoon B, Dey A, Nguyen VQ, Park JH. Latest progress in nitric oxide-generating nanomedicine for most cancers remedy. J Management Launch. 2022;352:179–98.
Wang L, Chang Y, Feng Y, Li X, Cheng Y, Jian H, Ma X, Zheng R, Wu X, et al. Nitric oxide stimulated programmable drug launch of nanosystem for multidrug resistance most cancers remedy. Nano Lett. 2019;19:6800–11.
Cheng H, Wang L, Mollica M, Re AT, Wu S, Zuo L. Nitric oxide in most cancers metastasis. Most cancers Lett. 2014;353:1–7.
Kim J, Thomas SN. Alternatives for nitric oxide in potentiating most cancers immunotherapy. Pharmacol Rev. 2022;74:1146–75.
Bellary A, Nowak C, Iwanicki I, Flores-Guzman F, Wu L, Kandel JJ, Laetsch TW, Bleris L, Hernandez SL, et al. Non-viral nitric oxide-based gene remedy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma fashions. Theranostics. 2023;13:3402–18.
Yuan Z, Lin C, He Y, Tao B, Chen M, Zhang J, Liu P, Cai Okay. Close to-infrared light-triggered nitric-oxide-enhanced photodynamic remedy and low-temperature photothermal remedy for biofilm elimination. ACS Nano. 2020;14:3546–62.
Chen H, Li T, Liu Z, Tang S, Tong J, Tao Y, Zhao Z, Li N, Mao C, et al. A nitric-oxide pushed chemotactic nanomotor for enhanced immunotherapy of glioblastoma. Nat Commun. 2023;14:941.
Wei T, Thakur SS, Liu M, Wen J. Oral supply of glutathione: antioxidant perform, limitations and techniques. Acta Materia Medica. 2022. https://doi.org/10.15212/AMM-2022-0005.
Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular drugs. Proc Natl Acad Sci USA. 2018;115:5839–48.
Wang S, Wang Y, Lv J, Xu C, Wei Y, Wang G, Li M. Distant manipulation of TRPV1 signaling by near-infrared light-triggered nitric oxide nanogenerators for particular most cancers remedy. Adv Healthc Mater. 2024;13: e2303579.
Huang W, Zhang J, Luo L, Yu Y, Solar T. Nitric oxide and tumors: from small-molecule donor to mixture remedy. ACS Biomater Sci Eng. 2023;9:139–52.
Yang Z, Yang C, Yang D, Zhang Y, Yang Q, Qu F, Guo W. l-Arginine-modified CoWO(4) /FeWO(4) S-scheme heterojunction enhances ferroptosis in opposition to stable tumor. Adv Healthc Mater. 2023;12: e2203092.
Li Z, Apizi Y, Zhang C, Wang Z, He H, Li X, Zhu Y, Yang J, Xiao L, et al. Synthesis of harmine-nitric oxide donor derivatives as potential antitumor brokers. Bioorg Med Chem Lett. 2022;65: 128698.
Wang F, Wu J, Yuan M, Yan Z, Liu X, Li W, Zhang Y, Sheng C, Liu N, et al. Novel nitric oxide donor-azole conjugation technique for environment friendly remedy of cryptococcus neoformans infections. J Med Chem. 2023;66:14221–40.
Huang Z, Fu J, Zhang Y. Nitric oxide donor-based most cancers remedy: advances and prospects. J Med Chem. 2017;60:7617–35.
Zou J, Li Z, Zhu Y, Tao Y, You Q, Cao F, Wu Q, Wu M, Cheng J, et al. pH/GSH twin responsive nanosystem for nitric oxide technology enhanced sort I photodynamic remedy. Bioact Mater. 2024;34:414–21.
Xu Q, Chen G, Chen G, Wu H, Yang Y, Mai Z, Solar R, Luan P, Guo C, et al. NO-dependent vasodilation and deep tumor penetration for cascade-amplified antitumor efficiency. J Management Launch. 2022;347:389–99.
Jia X, Zhang Y, Zou Y, Wang Y, Niu D, He Q, Huang Z, Zhu W, Tian H, et al. Twin intratumoral redox/enzyme-responsive NO-releasing nanomedicine for the precise, high-efficacy, and low-toxic most cancers remedy. Adv Mater. 2018;30: e1704490.
Wang X, Liu C, Chen X, Zhao X, Wu J, Chen H, Wan M, Zhao S, Li X, et al. A wise nitric oxide (NO) producing immuno-trimetallic nanocatalyst triggering chemodynamic remedy in breast most cancers remedy. Adv Funct Mater. 2024. https://doi.org/10.1002/adfm.202316186.
Teng L, Track G, Liu Y, Han X, Li Z, Wang Y, Huan S, Zhang XB, Tan W. Nitric oxide-activated “dual-key-one-lock” nanoprobe for in vivo molecular imaging and high-specificity most cancers remedy. J Am Chem Soc. 2019;141:13572–81.
Jiang D, Yue T, Wang G, Wang C, Chen C, Cao H, Gao Y. Peroxynitrite (ONOO−) technology from the HA-TPP@NORM nanoparticles primarily based on synergistic interactions between nitric oxide and photodynamic therapies for elevating anticancer effectivity. New J Chem. 2020;44:162–70.
Xu Z, Luo Q, He Y, He Y, Zhang X, Wang J, Ni S, Gao D, Wang D. Endogenous nitric oxide releases in situ for RNS/ROS synergistic most cancers remedy. Adv Funct Mater. 2024. https://doi.org/10.1002/adfm.202314536.
Huang X, Zhong Y, Li Y, Zhou X, Yang L, Zhao B, Zhou J, Qiao H, Huang D, et al. Black phosphorus-synergic nitric oxide nanogasholder spatiotemporally regulates tumor microenvironments for self-amplifying immunotherapy. ACS Appl Mater Interfaces. 2022;14:37466–77.
Yang HZ, Guo Y, Pu L, Yu XQ, Zhang J. Fluorescent self-reporting lipid nanoparticles for nitric oxide/gene co-delivery and mixture remedy. Mol Pharm. 2023;20:1404–14.
Wei G, Yang G, Wei B, Wang Y, Zhou S. Close to-infrared gentle switching nitric oxide nanoemitter for triple-combination remedy of multidrug resistant most cancers. Acta Biomater. 2019;100:365–77.
Zheng Y, Liu Y, Wei F, Xiao H, Mou J, Wu H, Yang S. Functionalized g-C(3)N(4) nanosheets for potential use in magnetic resonance imaging-guided sonodynamic and nitric oxide mixture remedy. Acta Biomater. 2021;121:592–604.
Wang PG, Xian M, Tang X, Wu X, Wen Z, Cai T, Janczuk AJ. Nitric oxide donors: chemical actions and organic purposes. Chem Rev. 2002;102:1091–134.
Li B, Ming Y, Liu Y, Xing H, Fu R, Li Z, Ni R, Li L, Duan D, et al. Latest developments in pharmacological impact, mechanism and utility prospect of diazeniumdiolates. Entrance Pharmacol. 2020;11:923.
Liu S, Cai X, Xue W, Ma D, Zhang W. Chitosan derivatives co-delivering nitric oxide and methicillin for the efficient remedy to the methicillin-resistant S. aureus an infection. Carbohydr Polym. 2020;234: 115928.
Chugunova EA, Burilov AR. Novel structural hybrids on the bottom of benzofuroxans and furoxans. Mini-review. Curr Prime Med Chem. 2017;17:986–1005.
Schulz V, Gross R, Pasch T, Busse J, Loeschcke G. Cyanide toxicity of sodium nitroprusside in therapeutic use with and with out sodium thiosulphate. Klin Wochenschr. 1982;60:1393–400.
Ghione S, Mabrouk N, Paul C, Bettaieb A, Plenchette S. Protein kinase inhibitor-based most cancers therapies: contemplating the potential of nitric oxide (NO) to enhance most cancers remedy. Biochem Pharmacol. 2020;176: 113855.
Han C, Yu Q, Jiang J, Zhang X, Wang F, Jiang M, Yu R, Deng T, Yu C. Bioenzyme-responsive L-arginine-based carbon dots: the replenishment of nitric oxide for nonpharmaceutical remedy. Biomater Sci. 2021;9:7432–43.
Fei Y, Wu J, An HW, Zhu Okay, Peng B, Cai J, Zhang Y, Li LL, Wang H, et al. Identification of latest nitric oxide-donating peptides with twin biofilm eradication and antibacterial actions for intervention of device-related infections. J Med Chem. 2020;63:9127–35.
Wang Y, Xie H, Wu Y, Xu S, Li Y, Li J, Xu X, Wang S, Li Y, et al. Bioinspired lipoproteins of furoxans-oxaliplatin transform bodily limitations in tumor to potentiate T-Cell infiltration. Adv Mater. 2022;34: e2110614.
Rose MJ, Mascharak PK. Fiat Lux: selective supply of excessive flux of nitric oxide (NO) to organic targets utilizing photoactive metallic nitrosyls. Curr Opin Chem Biol. 2008;12:238–44.
Woolum JC, Commoner B. Isolation and identification of a paramagnetic complicated from the livers of carcinogen-treated rats. Biochim Biophys Acta. 1970;201:131–40.
Sung YC, Jin PR, Chu LA, Hsu FF, Wang MR, Chang CC, Chiou SJ, Qiu JT, Gao DY, et al. Supply of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. Nat Nanotechnol. 2019;14:1160–9.
Hou Y, Wang J, Andreana PR, Cantauria G, Tarasia S, Sharp L, Braunschweiger PG, Wang PG. Focusing on nitric oxide to most cancers cells: cytotoxicity research of glyco-S-nitrosothiols. Bioorg Med Chem Lett. 1999;9:2255–8.
Melvin AC, Jones WM, Lutzke A, Allison CL, Reynolds MM. S-Nitrosoglutathione reveals better stability than S-nitroso-N-acetylpenicillamine underneath frequent laboratory situations: a comparative stability examine. Nitric Oxide. 2019;92:18–25.
Nagase S, Takemura Okay, Ueda A, Hirayama A, Aoyagi Okay, Kondoh M, Koyama A. A novel nonenzymatic pathway for the technology of nitric oxide by the response of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun. 1997;233:150–3.
Wan SS, Zeng JY, Cheng H, Zhang XZ. ROS-induced NO technology for gasoline remedy and sensitizing photodynamic remedy of tumor. Biomaterials. 2018;185:51–62.
Shi H, Xiong CF, Zhang LJ, Cao HC, Wang R, Pan P, Guo HY, Liu T. Gentle-triggered nitric oxide nanogenerator with excessive l-arginine loading for synergistic photodynamic/gasoline/photothermal remedy. Adv Healthc Mater. 2023;12: e2300012.
Zhou EY, Knox HJ, Reinhardt CJ, Partipilo G, Nilges MJ, Chan J. Close to-infrared photoactivatable nitric oxide donors with built-in photoacoustic monitoring. J Am Chem Soc. 2018;140:11686–97.
Sharma Okay, Iyer A, Sengupta Okay, Chakrapani H. INDQ/NO, a bioreductively activated nitric oxide prodrug. Org Lett. 2013;15:2636–9.
Ramachandran N, Jacob S, Zielinski B, Curatola G, Mazzanti L, Mutus B. N-dansyl-S-nitrosohomocysteine a fluorescent probe for intracellular thiols and S-nitrosothiols. Biochim Biophys Acta. 1999;1430:149–54.
He H, Liu Y, Zhou Z, Guo C, Wang HY, Wang Z, Wang X, Zhang Z, Wu FG, et al. A Picture-triggered and photo-calibrated nitric oxide donor: rational design, spectral characterizations, and organic purposes. Free Radic Biol Med. 2018;123:1–7.
Wu X, Wang M, Yu F, Cai H, Tedesco AC, Li Z, Bi H. Core-shell structured carbon dots with up-conversion fluorescence and photo-triggered nitric oxide-releasing properties. Analyst. 2024;149:1221–8.
Yang T, Zelikin AN, Chandrawati R. Progress and promise of nitric oxide-releasing platforms. Adv Sci. 2018;5:1701043.
Heinrich TA, da Silva RS, Miranda KM, Switzer CH, Wink DA, Fukuto JM. Organic nitric oxide signalling: chemistry and terminology. Br J Pharmacol. 2013;169:1417–29.
Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, Roberts DD, Wink DA. Molecular mechanisms for discrete nitric oxide ranges in most cancers. Nitric Oxide. 2008;19:73–6.
Soni Y, Softness Okay, Arora H, Ramasamy R. The Yin Yang function of nitric oxide in prostate most cancers. Am J Mens Well being. 2020;14:1557988320903191.
Yan Y, Wang CH, Cui SH, Zhai L, Solar J, Liu XY, Chen X, Solar Y, Qian HG, et al. Enhanced most cancers therapeutic effectivity of NO mixed with siRNA by caspase-3 responsive polymers. J Management Launch. 2021;339:506–20.
Cheng RYS, Burkett S, Ambs S, Moody T, Wink DA, Ridnour LA. Persistent publicity to nitric oxide induces P53 mutations and malignant-like options in human breast epithelial cells. Biomolecules. 2023;13:311.
Ren Z, Gu X, Lu B, Chen Y, Chen G, Feng J, Lin J, Zhang Y, Peng H. Anticancer efficacy of a nitric oxide-modified by-product of bifendate in opposition to multidrug-resistant most cancers cells. J Cell Mol Med. 2016;20:1095–105.
Liu Z, Zhong Y, Zhou X, Huang X, Zhou J, Huang D, Li Y, Wang Z, Dong B, et al. Inherently nitric oxide containing polymersomes remotely regulated by NIR for enhancing multi-modal remedy on drug resistant most cancers. Biomaterials. 2021;277: 121118.
Wan MM, Chen H, Da Wang Z, Liu ZY, Yu YQ, Li L, Miao ZY, Wang XW, Wang Q, et al. Nitric oxide-driven nanomotor for deep tissue penetration and multidrug resistance reversal in most cancers remedy. Adv Sci. 2020;8:2002525.
Deng Y, Wang Y, Jia F, Liu W, Zhou D, Jin Q, Ji J. Tailoring supramolecular prodrug nanoassemblies for reactive nitrogen species-potentiated chemotherapy of liver most cancers. ACS Nano. 2021;15:8663–75.
Rodkin S, Dzreyan V, Bibov M, Ermakov A, Derezina T, Kirichenko E. NO-dependent mechanisms of p53 expression and cell loss of life in Rat’s Dorsal Root ganglia after sciatic-nerve transection. Biomedicines. 2022;10:1664.
Gu C, Yao J, Solar P. Dynamin 3 suppresses development and induces apoptosis of hepatocellular carcinoma cells by activating inducible nitric oxide synthase manufacturing. Oncol Lett. 2017;13:4776–84.
Deng Y, Jia F, Chen X, Jin Q, Ji J. ATP suppression by pH-activated mitochondria-targeted supply of nitric oxide nanoplatform for drug resistance reversal and metastasis inhibition. Small. 2020;16: e2001747.
Jiang W, Dong W, Li M, Guo Z, Wang Q, Liu Y, Bi Y, Zhou H, Wang Y. Nitric oxide induces immunogenic cell loss of life and potentiates most cancers immunotherapy. ACS Nano. 2022;16:3881–94.
Menyailo ME, Bokova UA, Ivanyuk EE, Khozyainova AA, Denisov EV. Metastasis prevention: give attention to metastatic circulating tumor cells. Mol Diagn Ther. 2021;25:549–62.
Jing B, Luo Y, Lin B, Li J, Wang ZA, Du Y. Institution and utility of a dynamic tumor-vessel microsystem for learning totally different phases of tumor metastasis and evaluating anti-tumor medication. RSC Adv. 2019;9:17137–47.
Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the principle extracellular matrix (ECM) enzymes in collagen degradation, as a goal for anticancer medication. J Enzyme Inhib Med Chem. 2016;31:177–83.
Maishi N, Hida Okay. Tumor endothelial cells speed up tumor metastasis. Most cancers Sci. 2017;108:1921–6.
Pereira BP, do Valle GT, Salles BCC, Costa KCM, Ângelo ML, Torres LHL, Novaes RD, Ruginsk SG, Tirapelli CR, et al. Pyrrolidine dithiocarbamate reduces alloxan-induced kidney injury by lowering nox4, inducible nitric oxide synthase, and metalloproteinase-2. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:1899–910.
Gupta SK, Vlahakis NE. Integrin alpha9beta1 mediates enhanced cell migration by way of nitric oxide synthase exercise regulated by Src tyrosine kinase. J Cell Sci. 2009;122:2043–54.
Solar M, Sang Y, Deng Q, Liu Z, Ren J, Qu X. Particular technology of nitric oxide in mitochondria of most cancers cell for selective oncotherapy. Nano Res. 2022;15:5273–8.
Huang Y, Zhang J, Zhang Y, Shi L, Qin X, Lu B, Ding Y, Wang Y, Chen T, et al. P-glycoprotein suppression by photothermal-responsive nitric oxide rel easing nanoplatform for triple-combination remedy of multidrug resist ant most cancers. Mater Design. 2021;211: 110160.
Cao Y, Shi Y, Cai Y, Hong Z, Chai Y. The results of conventional Chinese language drugs on P-glycoprotein-mediated multidrug resistance and approaches for learning the herb-P-glycoprotein interactions. Drug Metab Dispos. 2020;48(10):972–9.
Ding Y, Ma Y, Du C, Wang C, Chen T, Wang Y, Wang J, Yao Y, Dong CM. NO-releasing polypeptide nanocomposites reverse most cancers multidrug resistance through triple therapies. Acta Biomater. 2021;123:335–45.
Riganti C, Miraglia E, Viarisio D, Costamagna C, Pescarmona G, Ghigo D, Bosia A. Nitric oxide reverts the resistance to doxorubicin in human colon most cancers cells by inhibiting the drug efflux. Can Res. 2005;65:516–25.
Hao T, Qian M, Zhang Y, Liu Q, Midgley AC, Liu Y, Che Y, Hou J, Zhao Q. An injectable dual-function hydrogel protects in opposition to myocardial ischemia/reperfusion harm by modulating ROS/NO disequilibrium. Adv Sci. 2022;9: e2105408.
Shi C, Cao P, Wang Y, Zhang Q, Zhang D, Wang Y, Wang L, Gong Z. PANoptosis: a cell loss of life characterised by pyroptosis, apoptosis, and necroptosis. J Inflamm Res. 2023;16:1523–32.
Singh P. Lim B focusing on apoptosis in most cancers. Curr Oncol Rep. 2022;24:273–84.
Pinsky DJ, Aji W, Szabolcs M, Athan ES, Liu Y, Yang YM, Kline RP, Olson KE, Cannon PJ. Nitric oxide triggers programmed cell loss of life (apoptosis) of grownup rat ventricular myocytes in tradition. Am J Physiol. 1999;277:H1189-1199.
Zhang X, Jin L, Tian Z, Wang J, Yang Y, Liu J, Chen Y, Hu C, Chen T, et al. Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma. Most cancers Sci. 2019;110:1054–63.
Yu H, Bai Y, Qiu J, He X, Xiong J, Dai Q, Wang X, Li Y, Sheng H, et al. Pseudomonas aeruginosa PcrV enhances the nitric oxide-mediated tumoricidal exercise of tumor-associated macrophages through a TLR4/PI3K/AKT/mTOR-glycolysis-nitric oxide circuit. Entrance Oncol. 2021;11: 736882.
Poderoso JJ, Helfenberger Okay, Poderoso C. The impact of nitric oxide on mitochondrial respiration. Nitric Oxide. 2019;88:61–72.
Vedenko A, Panara Okay, Goldstein G, Ramasamy R, Arora H. Tumor microenvironment and nitric oxide: ideas and mechanisms. Adv Exp Med Biol. 2020;1277:143–58.
Ghasemi M, Mayasi Y, Hannoun A, Eslami SM. Carandang R nitric oxide and mitochondrial perform in neurological illnesses. Neuroscience. 2018;376:48–71.
Valdez LB, Iglesias DE, Bombicino SS, Boveris A. Inhibition of mitochondrial complicated III by nitric oxide. Biochimica et Biophysica Acta (BBA) – Bioenergetics. 2012;1817:S93–4.
Gupta KJ, Kumari A, Florez-Sarasa I, Fernie AR, Igamberdiev AU. Interplay of nitric oxide with the parts of the plant mitochondrial electron transport chain. J Exp Bot. 2018;69:3413–24.
Salim T, Sershen CL, Might EE. Investigating the function of TNF-α and IFN-γ activation on the dynamics of iNOS gene expression in LPS stimulated macrophages. PLoS ONE. 2016;11: e0153289.
Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and loss of life. Nat Immunol. 2022;23:487–500.
Diederich M. Pure compound inducers of immunogenic cell loss of life. Arch Pharm Res. 2019;42:629–45.
Xu Y, Ren H, Liu J, Wang Y, Meng Z, He Z, Miao W, Chen G, Li X. A switchable NO-releasing nanomedicine for enhanced most cancers remedy and inhibition of metastasis. Nanoscale. 2019;11:5474–88.
Yuan Okay, Zhang C, Pan X, Hu B, Zhang J, Yang G. Immunomodulatory metal-based biomaterials for most cancers immunotherapy. J Management Launch. 2024;375:249–68.
Confino H, Sela Y, Epshtein Y, Malka L, Goldshtein M, Chaisson S, Lisi S, Avniel A, Monson JM, et al. Intratumoral administration of high-concentration nitric oxide and anti-mPD-1 remedy improves tumor regression charges and survival in CT26 tumor-bearing mice. Cells. 2023;12:2439.
Gao L, Yuan Z, Ma N, Zhou X, Huang X, Chen W, Qiao H. Nitric oxide polymersome-immobilized hydrogels for prevention of post- surgical tumor recurrence and metastasis. Chem Eng J. 2024;485: 149688.
Zhang Y, Zhou Z, Gao Z, Li X, Wang X, Zheng Z, Deng J, Liu D, Peng T, et al. Gentle photothermal remedy sensitized immune checkpoint blockade ther apy primarily based on ATP-exhausted nanoenzymes. Chem Eng J. 2023;474: 145677.
Xue Q, Yan Y, Zhang R, Xiong H. Regulation of iNOS on immune cells and its function in illnesses. Int J Mol Sci. 2018;19:3805.
Gullickson S, Snyder J, de Rio-Guerra R, Sweezy A, Vagher BL, Hogan T, Lahue Okay, Reisz J, Dlessandro A, et al. Nitric Oxide (NO) regulation of dendritic cells (DC) metabolism and immune effector features. J Immunol. 2023;210: 160.131.
Markowitz J, Wang J, Vangundy Z, You J, Yildiz V, Yu L, Foote IP, Branson OE, Stiff AR, et al. Nitric oxide mediated inhibition of antigen presentation from DCs to C D4+ T cells in most cancers and measurement of STAT1 nitration. Sci Rep. 2017;7:15424.
Kim J, Sestito LF, Im S, Kim WJ, Thomas SN. Poly(cyclodextrin)-polydrug nanocomplexes as artificial oncolytic virus for locoregional melanoma chemoimmunotherapy. Adv Funct Mater. 2020;30:1908788.
García-Ortiz A, Serrador JM. Nitric oxide signaling in T cell-mediated immunity. Developments Mol Med. 2018;24:412–27.
Liew EFY. Nitric oxide regulates T cell responses. Nitric Oxide. 2012;27:S8.
Navasardyan I, Bonavida B. Regulation of T cells in most cancers by nitric oxide. Cells. 2021;10:2655.
Zhu J. Thelper 2 (Th2) cell differentiation, sort 2 innate lymphoid cell (ILC2) growth and regulation of interleukin-4 (IL-4) and IL-13 manufacturing. Cytokine. 2015;75:14–24.
Webb DC, Cai Y, Matthaei KI, Foster PS. Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell perform. J Immunol. 2007;178:219–27.
Leyva-Castillo JM, Das M, Strakosha M, McGurk A, Artru E, Kam C, Alasharee M, Wesemann DR, Tomura M, et al. IL-4 acts on skin-derived dendritic cells to advertise the T(H)2 response to cutaneous sensitization and the event of allergic pores and skin irritation. J Allergy Clin Immunol. 2024. https://doi.org/10.1016/j.jaci.2024.06.021.
Kiwamoto T, Ishii Y, Morishima Y, Yoh Okay, Maeda A, Ishizaki Okay, Iizuka T, Hegab AE, Matsuno Y, et al. Transcription elements T-bet and GATA-3 regulate growth of airway transforming. Am J Respir Crit Care Med. 2006;174:142–51.
Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. Evolving cognition of the JAK-STAT signaling pathway: autoimmune issues and most cancers. Sign Transduct Goal Ther. 2023;8:204.
Stempelj M, Kedinger M, Augenlicht L, Klampfer L. Important function of the JAK/STAT1 signaling pathway within the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem. 2007;282:9797–804.
Palmieri EM, McGinity C, Wink DA, McVicar DW. Nitric oxide in macrophage immunometabolism: hiding in plain sight. Metabolites. 2020;10:429.
Drehmer D, Mesquita Luiz JP, Hernandez CAS, Alves-Filho JC, Hussell T, Townsend PA, Moncada S. Nitric oxide favours tumour-promoting irritation by way of mitochondria-dependent and -independent actions on macrophages. Redox Biol. 2022;54: 102350.
Cifone MG, Ulisse S, Santoni A. Pure killer cells and nitric oxide. Int Immunopharmacol. 2001;1:1513–24.
Park KG, Hayes PD, Garlick PJ, Sewell H, Eremin O. Stimulation of lymphocyte pure cytotoxicity by L-arginine. Lancet. 1991;337:645–6.
Lamas B, Vergnaud-Gauduchon J, Goncalves-Mendes N, Perche O, Rossary A, Vasson MP, Farges MC. Altered features of pure killer cells in response to L-Arginine availability. Cell Immunol. 2012;280:182–90.
Xiao L, Eneroth PH, Qureshi GA. Nitric oxide synthase pathway could mediate human pure killer cell cytotoxicity. Scand J Immunol. 1995;42:505–11.
Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra Okay, Campbell A, Gautam S, et al. Nitric oxide manufacturing by myeloid-derived suppressor cells performs a job in impairing Fc receptor-mediated pure killer cell perform. Clin Most cancers Res. 2018;24:1891–904.
Vong LB, Nagasaki Y. Nitric oxide nano-delivery techniques for most cancers therapeutics: advances and challenges. Antioxidants. 2020;9:791.
Huang L, Du M, Solar D, He M, Liu Z, Wu R, Jiang Y, Qi L, Wang J, et al. Propelling multi-modal therapeutics of PEEK implants by way of the facility of NO evolving covalent natural frameworks (COFs). Small. 2024;20: e2306508.
Wang L, Xie Y, Myrzagali S, Pu W, Liu E. Steel ions as effectual instruments for most cancers with conventional Chinese language drugs. Acupunct Herb Med. 2023;3:296–308.
Wang Y, Yang X, Chen X, Wang X, Wang Y, Wang H, Chen Z, Cao D, Yu L, et al. Sustained launch of nitric oxide and cascade technology of reactive nitrogen/oxygen species through an injectable hydrogel for tumor synergistic remedy. Adv Funct Supplies. 2022. https://doi.org/10.1002/adfm.202206554.
Liu R, Xiao W, Hu C, Xie R, Gao H. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimum measurement for combinational remedy of breast most cancers and lung metastasis. J Management Launch. 2018;278:127–39.
Liu C, Liu C, Bai Y, Wang J, Tian W. Drug self-delivery techniques: molecule design, development technique, and organic utility. Adv Healthc Mater. 2023;12: e2202769.
Solar T, Ding Y, Wang X, Zhang Okay, Zhang GP, Liang D, Yu Okay, Chu Y, Chen Q, et al. Carry-on nitric-oxide baggage for enhanced chemotherapeutic efficacy. Nano Lett. 2020;20:5275–83.
Dong X, Liu HJ, Feng HY, Yang SC, Liu XL, Lai X, Lu Q, Lovell JF, Chen HZ, et al. Enhanced drug supply by nanoscale integration of a nitric oxide donor to induce tumor collagen depletion. Nano Lett. 2019;19:997–1008.
Xiang H-J, Guo M, An L, Yang S-P, Zhang Q-L, Liu J-G. A multifunctional nanoplatform for lysosome focused supply of nitric oxide and photothermal remedy underneath 808 nm near-infrared gentle. J Mater Chem B. 2016;4:4667–74.
Solar F, Wang Y, Luo X, Ma Z, Xu Y, Zhang X, Lv T, Zhang Y, Wang M, et al. Anti-CD24 antibody-nitric oxide conjugate selectively and potently suppresses hepatic carcinoma. Most cancers Res. 2019;79:3395–405.
Yoshikawa T, Phan KQ, Tagawa H, Sasaki Okay, Feng H, Kishimura A, Mori T, Katayama Y. Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in stable tumors. Int J Pharm. 2020;583: 119352.
Wu W, Chen M, Luo T, Fan Y, Zhang J, Zhang Y, Zhang Q, Sapin-Minet A, Gaucher C, et al. ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to beat multidrug resistance in most cancers. Acta Biomater. 2020;103:259–71.
Hu Y, Lv T, Ma Y, Xu J, Zhang Y, Hou Y, Huang Z, Ding Y. Nanoscale coordination polymers for synergistic NO and chemodynamic remedy of liver most cancers. Nano Lett. 2019;19:2731–8.
Zhang M, Jin H, Liu Y, Wan L, Liu S, Zhang H. L-Arginine self-delivery supramolecular nanodrug for NO gasoline remedy. Acta Biomater. 2023;169:517–29.
Yu B, Deng Y, Jia F, Wang Y, Jin Q, Ji J. A Supramolecular nitric oxide nanodelivery system for prevention of tumor metastasis by inhibiting platelet activation and aggregation. ACS Appl Mater Interfaces. 2022;14:48515–26.
Xia M, Yan Y, Pu H, Du X, Liang J, Solar Y, Zheng J, Yuan Y. Glutathione responsive nitric oxide launch for enhanced photodynamic remedy by a porphyrinic MOF nanosystem. Chem Eng J. 2022;442: 136295.
Deepagan VG, Ko H, Kwon S, Rao NV, Kim SK, Um W, Lee S, Min J, Lee J, et al. Intracellularly activatable nanovasodilators to reinforce passive most cancers focusing on regime. Nano Lett. 2018;18:2637–44.
Tai L-A, Wang Y-C, Yang C-S. Warmth-activated sustaining nitric oxide launch from zwitterionic diaze niumdiolate loaded in thermo-sensitive liposomes. Nitric Oxide. 2010;23:60–4.
Garren M, Maffe P, Melvin A, Griffin L, Wilson S, Douglass M, Reynolds M. Handa H surface-catalyzed. Nitric oxide launch through a metallic natural framework enhances antibacterial floor results. ACS Appl Mater Interfaces. 2021;13:56931–43.
Wang J, Wu C, Qin X, Huang Y, Zhang J, Chen T, Wang Y, Ding Y, Yao Y. NIR-II gentle triggered nitric oxide launch nanoplatform mixed chemo-photothermal remedy for overcoming multidrug resistant most cancers. J Mater Chem B. 2021;9:1698–706.
Huang X, Solar W, Zhu Y, Zhao C, Tan B, Wang H-Y, Liu Y. A pH/gentle dual-responsive nanoprodrug to launch nitric oxide and ROS for Cascade photodynamic remedy. Sens Actuators, B Chem. 2024;408: 135522.
Zhao Y, Shi D, Guo L, Shang M, Solar X, Meng D, Xiao S, Wang X, Li J. Ultrasound focused microbubble destruction-triggered nitric oxide launch through nanoscale ultrasound distinction agent for sensitizing chemoimmunotherapy. J Nanobiotechnol. 2023;21:35.
Fan Y, Wu W, Luo T, Hu Y, Zhang Q, Zhang J, Xia X. Cross-linking of S-nitrosothiolated AIEgens inside most cancers cells to watch NO launch and reverse chemo-resistance. Chem Commun. 2021;57:12520–3.
Wang J, Yang Y, Yu M, Hu G, Gan Y, Gao H, Shi X. Diffusion of rod-like nanoparticles in non-adhesive and adhesive porou s polymeric gels. J Mech Phys Solids. 2017;112:431–57.
Zhang Y, Mou H, Huang Q, Jian C, Li X, Chen S, Chen Y, Tao B, Ou Y. Engineering of phytic acid-coated Prussian nanoparticles for mixed nitric oxide and low-temperature photothermal remedy of osteosarcoma. Chem Eng J. 2024;491: 151730.
Deng Y, Jia F, Chen S, Shen Z, Jin Q, Fu G, Ji J. Nitric oxide as an all-rounder for enhanced photodynamic remedy: hypoxia aid, glutathione depletion and reactive nitrogen species technology. Biomaterials. 2018;187:55–65.
Mu J, He L, Fan W, Tang W, Wang Z, Jiang C, Zhang D, Liu Y, Deng H, et al. Cascade reactions catalyzed by planar metal-organic framework hybrid structure for mixed most cancers remedy. Small. 2020;16:2004016.
Yang L, Gao P, Huang Y, Lu X, Chang Q, Pan W, Li N, Tang B. Boosting the photodynamic remedy effectivity with a mitochondria-targeted nanophotosensitizer. Chin Chem Lett. 2019;30:1293–6.
Zhou S, Wu C, Shen P, Zhou L, Wang W, Lv Okay, Wei C, Li G, Ma D, et al. Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide mixed most cancers remedy. Chem Eng J. 2024;481: 148618.
Ji C, Si J, Xu Y, Zhang W, Yang Y, He X, Xu H, Mou X, Ren H, et al. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and improve sonodynamic remedy for immune activation. Theranostics. 2021;11:8587–604.
Bai Q, Wang M, Liu J, Solar X, Yang P, Qu F, Lin H. Porous molybdenum nitride nanosphere as carrier-free and environment friendly nitric oxide donor for synergistic nitric oxide and chemo/sonodynamic remedy. ACS Nano. 2023;17:20098–111.
Fu J, Wu Q, Dang Y, Lei X, Feng G, Chen M, Yu XY. Synergistic remedy utilizing doxorubicin-loading and nitric oxide-generating hole Prussian blue nanoparticles with photoacoustic imaging potential in opposition to breast most cancers. Int J Nanomed. 2021;16:6003–16.
Wang M, Zhang M, Bi J, Li J, Hu X, Zhang L, Zhang Y, Wang W, Lin Y, et al. Mitochondrial focused thermosensitive nanocarrier for near-infrared-triggered exact synergetic photothermal nitric oxide chemotherapy. ACS Appl Mater Interfaces. 2024;16:18252–67.
Ding M, Shao Okay, Wu L, Jiang Y, Cheng B, Wang L, Shi J, Kong XA. A NO/ROS/RNS cascaded-releasing nano-platform for gasoline/PDT/PTT/immunoth erapy of tumors. Biomater Sci. 2021;9:5824–40.
Mohapatra A, Mondal J, Sathiyamoorthy P, Mohanty A, Revuri V, Rajendrakumar SK, Lee YK, Park IK. Thermosusceptible nitric-oxide-releasing nitrogel for strengthening antitumor immune responses with tumor collagen diminution and deep tissue supply throughout NIR laser-assisted photoimmunotherapy. ACS Appl Mater Interfaces. 2023. https://doi.org/10.1021/acsami.3c01896.
Chen H, Shi T, Wang Y, Liu Z, Liu F, Zhang H, Wang X, Miao Z, Liu B, et al. Deep penetration of nano stage medication and micrometer-level T Cells promoted by nanomotors for most cancers immunochemotherapy. J Am Chem Soc. 2021;143:12025–37.
Theivendran S, Gu Z, Tang J, Yang Y, Track H, Yang Y, Zhang M, Cheng D, Yu C. Nanostructured organosilica nitric oxide donors intrinsically regulate macrophage polarization with antitumor impact. ACS Nano. 2022;16:10943–57.
Li Y, Qian H, Huang X, Zhou X, Zhao B, Yang L, Chen J, Qiao H, Huang D, et al. Up-converted nano-gasholder with exact nitric oxide launch remodels immunosuppressive microenvironment and potentiates tumor immunotherap y. Nano At the moment. 2022;42: 101381.
Dai X, Liu X, Wang X, Zhang Y, Li Y, Gao F. Cascade-targeted nanoplatforms for synergetic antibiotic/ROS/NO/immunotherapy in opposition to intracellular bacterial an infection. Biomacromol. 2024;25:3190–9.
Zhao Y, Wang S, Yao S, Wan X, Hu Q, Zheng M, Wang Z, Li L. Piezoelectric Ba(0.85) Sr(0.15) TiO(3) nanosonosensitizer with nitric oxide supply for enhancing most cancers remedy. Small Strategies. 2024;8: e2301134.
Wang Y, Bi Okay, Shu J, Liu X, Xu J, Deng G. Ultrasound-controlled DOX-SiO(2) nanocomposites improve the antitumour efficacy and attenuate the toxicity of doxorubicin. Nanoscale. 2019;11:4210–8.
Faria RS, de Lima LI, Bonadio RS, Longo JPF, Roque MC, de Matos NJN, Moya SE, de Oliveira MC, Azevedo RB. Liposomal paclitaxel induces apoptosis, cell loss of life, inhibition of migration capability and antitumoral exercise in ovarian most cancers. Biomed Pharmacother. 2021;142: 112000.
Wang X, Zhuang Y, Wang Y, Jiang M, Yao L. The latest developments of camptothecin and its derivatives as potential anti-tumor brokers. Eur J Med Chem. 2023;260: 115710.
Ahmadijokani F, Tajahmadi S, Rezakazemi M, Sehat AA, Molavi H, Aminabhavi TM, Arjmand M. Aluminum-based metal-organic frameworks for adsorptive removing of anti-cancer (methotrexate) drug from aqueous options. J Environ Handle. 2021;277: 111448.
Fu X, He Y, Li M, Huang Z, Najafi M. Focusing on of the tumor microenvironment by curcumin. BioFactors. 2021;47:914–32.
Gao Z, You C, Wu H, Wang M, Zhang X, Solar B. FA and cRGD twin modified lipid-polymer nanoparticles encapsulating polyaniline and cisplatin for extremely efficient chemo-photothermal mixture remedy. J Biomater Sci Polym Ed. 2018;29:397–411.
Li C, Cheng Y, Li D, An Q, Zhang W, Zhang Y, Fu Y. Antitumor purposes of photothermal brokers and photothermal synergistic therapies. Int J Mol Sci. 2022;23:7909.
Shi Y, Zhou M, Zhang Y, Wang Y, Cheng J. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal remedy and chemodynamic remedy. Acta Biomater. 2023;158:571–82.
Zhang H, Wang X, Yang X, Wu Z, Chen Q, Wei Q, Guo Y, Hu Q, Shen JW. NIR-triggered and thermoresponsive core-shell nanoparticles for synergistic anticancer remedy. J Management Launch. 2024;374:194–204.
Lei H, Pei Z, Jiang C, Cheng L. Latest progress of metal-based nanomaterials with anti-tumor organic results for enhanced most cancers remedy. Exploration. 2023;3:20220001.
Liu X, Zhang C, Zhang C, Li J, Guo W, Yan D, Yang C, Zhao J, Xia T, et al. Warmth shock protein 70 inhibits cardiomyocyte necroptosis by way of repressing autophagy in myocardial ischemia/reperfusion harm. In Vitro Cell Dev Biol Anim. 2016;52:690–8.
Xu Y, Wang S, Chen Z, Hu R, Zhao Y, Wang Okay, Qu J, Liu L. Nitric oxide launch activated near-Infrared photothermal agent for synergistic tumor remedy. Biomaterials. 2021;276: 121017.
Yang J, Qi W, Wang L, He L, Ou C, Xu C, He D, Deng L. Close to-infrared-guided NO generator for mixed NO/photothermal/chemodynamic remedy of bacterial infections. Acta Biomater. 2024;176:379–89.
Niculescu A-G, Grumezescu AM. Photodynamic remedy—an up-to-date overview. Appl Sci. 2021;11:3626.
Wu P, Liu X, Duan Y, Pan L, Solar Z, Chu H, Zhu C, Liu B. ZnPc photosensitizer-loaded peony-shaped FeSe2 remotely managed by near-infrared gentle for antimycobacterial remedy. Acta Materia Medica. 2023. https://doi.org/10.15212/AMM-2023-0012.
Solar H, Feng M, Chen S, Wang R, Luo Y, Yin B, Li J, Wang X. Close to-infrared photothermal liposomal nanoantagonists for amplified most cancers photodynamic remedy. J Mater Chem B. 2020;8:7149–59.
Luby BM, Walsh CD, Zheng G. Superior photosensitizer activation methods for smarter photodynamic remedy beacons. Angew Chem Int Ed Engl. 2019;58:2558–69.
Yu H, Tiemuer A, Yao X, Zuo M, Wang H-Y, Liu Y, Chen X. Mitochondria-specific near-infrared photoactivation of peroxynitrite upconversion luminescent nanogenerator for precision most cancers gasoline remedy. Acta Pharmaceutica Sinica B. 2024;14:378–91.
Luo T, Wang D, Liu L, Zhang Y, Han C, Xie Y, Liu Y, Liang J, Qiu G, et al. Switching reactive oxygen species into reactive nitrogen species by photocleaved O(2) -released nanoplatforms favors hypoxic tumor repression. Adv Sci. 2021;8: e2101065.
Zhang B, Lin L, Mao J, Mo W, Li Z, Wang S, Tang Y, Cui C, Wu Y, et al. Self-oxygenated co-assembled biomimetic nanoplatform for enhanced phot odynamic remedy in hypoxic tumor. Chin Chem Lett. 2023;34: 108518.
Su MC, Nethi SK, Dhanyamraju PK, Prabha S. Nanomedicine methods for focusing on tumor stroma. Cancers. 2023;15:4145.
Sandha KK, Shukla MK, Gupta PN. Latest advances in methods for extracellular matrix degradation and synthesis inhibition for improved remedy of stable tumors. Curr Pharm Des. 2020;26:5456–67.
Ma C, Zhang J, Zhang T, Solar H, Wu J, Shi J, Xie Z. Evaluating the rod-like and spherical BODIPY nanoparticles in mobile imaging. Entrance Chem. 2019;7:765.
Jiang L, Chen D, Jin Z, Xia C, Xu Q, Fan M, Dai Y, Liu J, Li Y, et al. Gentle-triggered nitric oxide launch and construction transformation of peptide for enhanced intratumoral retention and sensitized photodynamic remedy. Bioact Mater. 2022;12:303–13.
Zhou LQ, Li P, Cui XW, Dietrich CF. Ultrasound nanotheranostics in preventing most cancers: advances and prospects. Most cancers Lett. 2020;470:204–19.
Lei P, Li M, Dong C, Shuang S. Multifunctional mitochondria-targeting near-infrared fluorescent probe for viscosity, ONOO(-), mitophagy, and bioimaging. ACS Biomater Sci Eng. 2023;9:3581–9.
Yang M, Xu Y, Heisner JS, Solar J, Stowe DF, Kwok WM, Camara AKS. Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and affiliation with hexokinase II in mitochondria. Mitochondrion. 2019;46:380–92.
Zhou C, Liu Q, Xiang Y, Gou X, Li W. Function of the tumor immune microenvironment in tumor immunotherapy. Oncol Lett. 2022;23:53.
Seliger B, Massa C. Immune remedy resistance and immune escape of tumors. Cancers (Basel). 2021;13:551.
PeÑarando J, Aranda E, RodrÍguez-Ariza A. Immunomodulatory roles of nitric oxide in most cancers: tumor microenvironment says “NO” to antitumor immune response. Transl Res. 2019;210:99–108.
Yu S, Shen H, Chen X, Wang H, He C, Hu T, Cao G, Zhang L. A cascade nanosystem with “Triple-Linkage” impact for enhanced photothermal and activatable metallic ion remedy for hepatocellular carcinoma. J Nanobiotechnol. 2024;22:334.
Wang Z, Jin A, Yang Z, Huang W. Superior nitric oxide producing nanomedicine for therapeutic purposes. ACS Nano. 2023;17:8935–65.
Chung AW, Anand Okay, Anselme AC, Chan AA, Gupta N, Venta LA, Schwartz MR, Qian W, Xu Y, et al. A part 1/2 scientific trial of the nitric oxide synthase inhibitor L-NM. Sci Transl Med. 2021;13: eajb5070.
Dingemans AMC, Groen HJM, Herder GJM, Stigt JA, Smit EF, Bahce I, Burgers JA, van den Borne BEEM, Biesma B, et al. A randomized part II examine evaluating paclitaxel–carboplatin–bevacizum ab with or with out nitroglycerin patches in sufferers with stage IV non squamous nonsmall-cell lung most cancers: NVALT12 (NCT01171170). Ann Oncol. 2015;26:2286–93.
Sinha BK. Can nitric oxide-based remedy be improved for the remedy of cancers? A perspective. Int J Mol Sci. 2023;24:13611.
Zhang S, Li M, Wang J, Zhou Y, Dai P, Zhao M, Lv W, Liu S, Zhao Q. NIR-triggered on-demand nitric oxide launch for enhanced synergistic phototherapy of hypoxic tumor. Bioconjug Chem. 2023;34:1327–35.
